Polydex Financial Statements From 2010 to 2024
| POLXFDelisted Stock | USD 1.96 0.01 0.51% |
Check Polydex Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Polydex Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Polydex financial statements analysis is a perfect complement when working with Polydex Pharmaceuticals Valuation or Volatility modules.
Polydex |
Polydex Pharmaceuticals Company Return On Equity Analysis
Polydex Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Polydex Pharmaceuticals Return On Equity | -0.18 |
Most of Polydex Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Polydex Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Polydex Pharmaceuticals has a Return On Equity of -0.1802. This is 99.25% lower than that of the Pharmaceuticals sector and 99.51% lower than that of the Health Care industry. The return on equity for all United States stocks is 41.87% lower than that of the firm.
Polydex Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Polydex Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Polydex Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Polydex Pharmaceuticals competition to find correlations between indicators driving Polydex Pharmaceuticals's intrinsic value. More Info.Polydex Pharmaceuticals is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Polydex Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Polydex Pharmaceuticals Financial Statements
Polydex Pharmaceuticals stakeholders use historical fundamental indicators, such as Polydex Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Polydex Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Polydex Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Polydex Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Polydex Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada. Polydex Pharm operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |